Ing Groep Nv Global Blood Therapeutics, Inc. Transaction History

Ing Groep Nv

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$45.35 - $57.91 $272,100 - $347,460	-6,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$52.6 - $63.29 $315,600 - $379,740	6,000 New	6,000 $316,000
Q3 2018 Nov 06, 2018	SELL	$38.0 - $51.1 $1.65 Million - $2.22 Million	-43,483 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$38.7 - $50.15 $1.68 Million - $2.18 Million	43,483 New	43,483 $1.97 Million
Q1 2018 May 07, 2018	SELL	$39.6 - $65.9 $5.39 Million - $8.97 Million	-136,175 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$29.7 - $45.7 $4.04 Million - $6.22 Million	136,175	136,175 $5.36 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.